A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca reports positive high-level results from Phase 3 study of eplontersen to treat hereditary transthyretin-mediated amyloid polyneuropathy; ATTRv-PN is a rare, progressive disease that leads to peripheral nerve damage with motor disability
Published: March 27, 2023 by dpa-AFX International Compact
Pfizer and Astellas report Phase 3 study shows Xtandi enzalutamide plus leuprolide significantly improves metastasis-free survival in men with non-metastatic prostate cancer
Published: March 17, 2023 by Contify Life Science News
GSK announces positive results from phase III trial of 5-in-1 meningococcal ABCWY vaccine candidate
Published: March 15, 2023 by PharmaBiz (India)
Weekly antibody treatment with dupilumab improved chronic food allergy symptoms in young adults with eosinophilic esophagitis; about 30% to 40% of patients do not respond to current treatments that include food elimination diets, proton-pump inhibitors
Published: March 10, 2023 by Indian Health Care News
AstraZeneca reports trial results showing Imfinzi improves lung cancer survival; drug given in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery
Published: March 09, 2023 by M2 Pharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count